Bitetti Teresa Marie 4
4 · Fusion Pharmaceuticals Inc. · Filed Oct 16, 2023
Insider Transaction Report
Form 4
Bitetti Teresa Marie
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-10-16+34,000→ 34,000 totalExercise: $4.16Exp: 2033-10-16→ Common Stock (34,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 36 substantially equal monthly installments starting on November 16, 2023.